Paradigm Medical Industries, Inc.
PDMI · OTC
3/31/2009 | 12/31/2008 | 9/30/2008 | 6/30/2008 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.00 | 0.00 |
| FCF Yield | -197,239.74% | -124,238.97% | -418,570.08% | -200,549.45% |
| EV / EBITDA | -12.91 | -14.72 | -40.06 | -9.31 |
| Quality | ||||
| ROIC | -13.90% | 319.23% | 34.99% | 153.27% |
| Gross Margin | 53.59% | 45.61% | 46.44% | 42.72% |
| Cash Conversion Ratio | 0.29 | 0.06 | 0.43 | 0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.80% | -16.92% | -4.76% | -5.57% |
| Free Cash Flow Growth | -245.83% | 79.31% | -58.90% | 74.91% |
| Safety | ||||
| Net Debt / EBITDA | -12.91 | -14.72 | -40.06 | -9.31 |
| Interest Coverage | 1.16 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.11 | 0.29 | 0.29 | 0.13 |
| Cash Conversion Cycle | 307.41 | 144.65 | 173.13 | 368.77 |